Learn how "sell to close" closes an options trade, its workings, and examples of profitable and loss scenarios. Empower your ...

Want to sell your home before Christmas? Here's the date you need to list it for sale - Homes in London are currently taking ...

Brits are sitting on a hidden goldmine of old forgotten tech devices that may be gathering dust in the attic, according to a ...

EXCLUSIVE: The Express has spoken to an expert who shared his top four tips for protecting your garden before the cold ...

Save 20% on a watch that'll brave the elements with you. TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Whether you ...

Amgen Inc. (NASDAQ:AMGN) is one of the best large cap value stocks to buy now. On September 26, Bank of America Securities analyst Tim Anderson maintained a Sell rating on Amgen Inc. (NASDAQ:AMGN) and ...

Bill Ackman discusses his short selling strategies, including his experiences with Herbalife (a pyramid scheme) and his successful short of MBIA. Originally recorded at Oxford in 2013. See which ...

Ever wanted to get your hands on a 30-foot tall animatronic dinosaur? Whether the possibility have ever crossed your mind or not, there's a life-size dinosaur fire sale happening in New Jersey in ...

To promote preorders for the ROG Xbox Ally and Xbox Ally X, Asus looked to one of the most popular video games of all time: Grand Theft Auto V. Michael De Santa actor Ned Luke and Franklin Clinton ...

Bond investors aren’t known for seeking out excitement. When it comes to the kind of metrics fixed income traders are looking for to sell to their clients, bland is a lot more attractive than bold.

Stock market today: Vaishali Parekh of Prabhudas Lilladher believes Indian stock market sentiment has turned cautious as the Nifty 50 index has slipped below 25,000 levels and came close to its ...

Investing.com - Goldman Sachs downgraded Apellis Pharmaceuticals (NASDAQ:APLS) from Neutral to Sell and lowered its price target to $18.00, citing concerns about the growth trajectory of the company’s ...